(PharmaNewsWire.Com, May 03, 2017 ) Regenerative medicine is a process of regenerating cells, tissues, and organs to restore normal function in a diseased organ. This branch of tissue engineering and molecular biology is promising and is driven by demand from patients, development of cell therapy, tissue scaffold, and gene therapy products, and increase in the number of pipeline products.
Publisher's analysts forecast the global regenerative medicine market to grow at a CAGR of 20.7% during the period 2016-2020. For more information about this report: http://www.reportsweb.com/global-regenerative-medicine-market-2016-2020 Covered in this report The report covers the present scenario and the growth prospects of the global regenerative medicine market for 2016-2020. To calculate the market size, we used the revenue generated from the sales of various types of regenerative medicine products.
The market is divided into the following segments based on geography: -Americas -APAC -EMEA
Publisher's report, Global Regenerative Medicine Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors -Acelity -Medtronic -MiMedx Group -Organogenesis -UniQure -Zimmer Biomet
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: